SureTrader Advertisement Advertisement
Home > Boards > US Listed > Biotechs > Peregrine Pharmaceuticals (PPHM)

Just to be clear, they didn't "let" options

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
cheynew Member Profile
Member Level 
Followed By 48
Posts 11,439
Boards Moderated 0
Alias Born 09/03/01
160x600 placeholder
Peregrine Pharmaceuticals to Participate in Two Upcoming Life Science Investor Conferences "GlobeNewswire Inc." - 11/23/2015 8:05:00 AM
Feature Analyst Alert and 4 Brief Updates "InvestorsHub NewsWire" - 11/10/2015 8:00:00 AM
New Preclinical Data Presented at SITC Annual Meeting Highlight Bavituximab’s Enhanced Anti-Tumor Activity When Combined Wi... "GlobeNewswire Inc." - 11/9/2015 8:05:00 AM
Peregrine Pharmaceuticals' Stock Sank in September: Is It Now a Buy? "The Motley Fool" - 10/17/2015 7:03:03 AM
AstraZeneca and Peregrine Pharmaceuticals Expand Ongoing Immuno-Oncology Collaboration to Include Phase II Lung Cancer Combin... "GlobeNewswire Inc." - 10/15/2015 8:05:00 AM
Peregrine Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2016 and Recent Developments "GlobeNewswire Inc." - 9/21/2015 8:46:28 PM
Biotechnology Stocks Technical Study -- Exelixis, XOMA Corp., Enzon Pharma, Peregrine Pharma, and StemCells "PR Newswire (US)" - 9/21/2015 8:50:00 AM
3 Key Takeaways From Peregrine Pharmaceuticals' Fourth-Quarter Results "The Motley Fool" - 7/15/2015 5:10:02 PM
Peregrine Pharmaceuticals Q4 Earnings Preview "The Motley Fool" - 7/10/2015 4:02:02 PM
Small Cap Stocks to Watch in Biotech "The Motley Fool" - 6/30/2015 12:02:03 PM
Undervalued and Underexposed NYSE-MKT Stock to be Profiled by Large Media Group and four brief reports "InvestorsHub NewsWire" - 6/15/2015 7:00:00 AM
1 Drug Will Make or Break These 3 Biotech Stocks "The Motley Fool" - 6/13/2015 7:18:02 AM
Special Profile & Four Companies Where Investors are Anticipating Success "InvestorsHub NewsWire" - 6/3/2015 7:00:00 AM
Peregrine Pharmaceuticals' Immuno-Oncology Agent Bavituximab to be Highlighted in Three Presentations at 2015 ASCO Annual Mee... "GlobeNewswire Inc." - 5/13/2015 5:00:00 PM
*Special Analyst Alert* and 4 Companies that are Worth a Look "InvestorsHub NewsWire" - 5/13/2015 7:00:00 AM
Preclinical Data Presented at AACR Demonstrate Synergistic Anti-Tumor Effects of Peregrine Pharmaceuticals' Phosphatidylserin... "GlobeNewswire Inc." - 4/21/2015 8:00:00 AM
Peregrine Pharmaceuticals Given a $5.00 Price Target at Roth Capital (PPHM) "Analyst Ratings Network" - 4/20/2015 3:24:37 PM
Data Presented at AACR Demonstrate Peregrine Pharmaceuticals' Bavituximab Induces Immune Activation in PD-L1 Negative NSCLC T... "GlobeNewswire Inc." - 4/20/2015 8:00:00 AM
Peregrine Pharmaceuticals Announces Three Abstracts Accepted for Presentation at AACR 2015 Annual Meeting "GlobeNewswire Inc." - 4/14/2015 8:00:00 AM
5 Promising Biotech Stocks Under $10 "The Motley Fool" - 4/3/2015 8:04:02 AM
Peregrine Pharmaceuticals Announces Promising Bavituximab Phase I Data Published in the Peer-Reviewed Journal Cancer Medicine... "GlobeNewswire Inc." - 3/31/2015 12:45:22 PM
Peregrine Pharmaceuticals Reports Third Quarter Fiscal Year 2015 Financial Results and Recent Developments "GlobeNewswire Inc." - 3/12/2015 4:00:00 PM
Independent Research Initiates Analyst Coverage on Inventergy Global, Inc. (NASDAQ: INVT) with $1.20 Price Target "InvestorsHub NewsWire" - 3/12/2015 8:00:00 AM
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock "GlobeNewswire Inc." - 3/10/2015 4:00:00 PM
Peregrine Pharmaceuticals to Report Third Quarter Fiscal 2015 Financial Results After Market on March 12, 2015 "GlobeNewswire Inc." - 3/5/2015 4:00:00 PM
cheynew Member Level  Thursday, 05/24/12 06:25:25 AM
Re: Threes post# 80517
Post # of 243670 
Just to be clear, they didn't "let" options expire. They were out of the money at the expiration date, so they died a natural death. They didn't take advantage of options at .46, the BOD awarded them. They have no cost until they are exercised, then they usually do a net sale transaction where they take the difference between the exercise price and the pps at the date of exercise. I hope they make a ton of money on these new options and the sooner the better.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist